Baupost Group
13F Holdings and Portfolio Analysis
Seth Klarman 2018 Q1 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
Baupost Group Overview
Baupost Group held 33 stocks in 2018 Q1, with total market value around $10.37B.
Baupost Group's top five holdings in 2018 Q1: CHENIERE ENERGY INC 10.68%, Synchrony Financial(SYF) 9.47%, TWENTY FIRST CENTY FOX INC CL A(FOXA) 9.41%, VIASAT INC(VSAT) 8.66%, ALLERGAN PFD CONV SER A 7.71%.
- Portfolio Value
- $10.37B
- Current Holdings
- 33 stocks
- New / Increased
- 2 / 11
- Reduced / Exited
- 4 / 3
Current Holdings
| 1 | CHENIERE ENERGY INCCUSIP 16411R208 | 1.11 | 10.68% | 20.73 - | $53.45 | - | $42.98 | 0.00 | 4.25 | +$0.22B+24.37% | Held |
| 2 | Synchrony FinancialSYF | 0.98 | 9.47% | 29.30 - | $33.53 | $72.84 +117.24% | $29.47 | 0.00 | 1.75 | +$1.27B+147.16% | Held |
| 3 | TWENTY FIRST CENTY FOX INC CL AFOXA | 0.98 | 9.41% | 26.59 +19.29% | $36.69 | - | $29.30 | +4.30 | 2.75 | +$0.20B+25.23% | Increased |
| 4 | VIASAT INCVSAT | 0.90 | 8.66% | 13.66 +3.80% | $65.72 | - | $70.36 | +0.50 | 5.00 | -$0.06B-6.59% | Increased |
| 5 | ALLERGAN PFD CONV SER ACUSIP G0177J108 | 0.80 | 7.71% | 4.75 +5.56% | $168.29 | - | $214.93 | +0.25 | 2.25 | -$0.22B-21.70% | Increased |
| 6 | QORVO INCCUSIP 74736K101 | 0.77 | 7.47% | 11.00 - | $70.45 | - | $67.34 | 0.00 | 1.25 | +$0.03B+4.62% | Held |
| 7 | TIME WARNER INC COM NEWCUSIP 887317303 | 0.77 | 7.39% | 8.10 - | $94.58 | - | $91.47 | 0.00 | 0.50 | +$0.03B+3.40% | Held |
| 8 | PIONEER NAT RES COCUSIP 723787107 | 0.69 | 6.63% | 4.00 +100.00% | $171.78 | - | $172.13 | +2.00 | 0.75 | -$0.00B-0.20% | Increased |
| 9 | ANTERO RES CORPCUSIP 03674X106 | 0.53 | 5.09% | 26.59 +7.55% | $19.85 | - | $16.92 | +1.87 | 3.75 | +$0.08B+17.31% | Increased |
| 10 | TWENTY FIRST CENTY FOX INC CL BCUSIP 90130A200 | 0.42 | 4.01% | 11.43 +8.57% | $36.37 | - | $29.81 | +0.90 | 2.75 | +$0.08B+22.02% | Increased |
| 11 | CARDINAL HEALTH INCCAH | 0.32 | 3.08% | 5.10 - | $62.68 | - | $67.25 | 0.00 | 1.50 | -$0.02B-6.79% | Held |
| 12 | COLONY NORTHSTAR INCCUSIP 19625W104 | 0.28 | 2.69% | 49.69 +3.72% | $5.62 | - | $12.65 | +1.78 | 1.25 | -$0.35B-55.57% | Increased |
| 13 | PBF ENERGY INCCUSIP 69318G106 | 0.27 | 2.59% | 7.92 -27.46% | $33.90 | - | $37.75 | -3.00 | 4.75 | -$0.03B-10.20% | Reduced |
| 14 | ATARA BIOTHERAPEUTICS INCCUSIP 046513107 | 0.24 | 2.35% | 6.25 +16.70% | $39.00 | - | $32.86 | +0.90 | 3.50 | +$0.04B+18.67% | Increased |
| 15 | MCKESSON CORP COMMCK | 0.23 | 2.19% | 1.62 +18.80% | $140.87 | $742.44 +427.04% | $152.84 | +0.26 | 0.75 | +$0.95B+385.77% | Increased |
| 16 | THERAVANCE BIOPHARMA INCCUSIP G8807B106 | 0.23 | 2.18% | 9.31 - | $24.25 | - | $30.35 | 0.00 | 4.00 | -$0.06B-20.10% | Held |
| 17 | VERITIV CORPCUSIP 923454102 | 0.15 | 1.45% | 3.82 +5.02% | $39.20 | - | $43.60 | +0.18 | 3.75 | -$0.02B-10.09% | Increased |
| 18 | P G & E CORPPCG | 0.14 | 1.33% | 3.15 | $43.93 | - | $43.93 | +3.15 | 0.25 | $0.00B0.00% | New |
| 19 | AMERISOURCEBERGEN CORPCUSIP 03073E105 | 0.11 | 1.10% | 1.32 -8.18% | $86.21 | - | $90.63 | -0.12 | 0.75 | -$0.01B-4.87% | Reduced |
| 20 | KERYX BIOPHARMACEUTICALS INCCUSIP 492515101 | 0.11 | 1.02% | 25.79 - | $4.09 | - | $14.16 | 0.00 | 4.25 | -$0.26B-71.12% | Held |
| 21 | AMC ENTMT HLDGS INCCUSIP 00165C104 | 0.07 | 0.68% | 5.00 - | $14.05 | - | $14.81 | 0.00 | 0.75 | -$0.00B-5.16% | Held |
| 22 | NOVAGOLD RES INCCUSIP 66987E206 | 0.06 | 0.56% | 13.47 +25.36% | $4.33 | - | $3.47 | +2.72 | 5.00 | +$0.01B+24.74% | Increased |
| 23 | TESLA INC CV SR UNSEC NTCUSIP 88160RAD3可转换债券 | 0.05 | 0.50% | 50.00 | $1.04 | - | $1.04 | +50.00 | 0.25 | $0.00B0.00% | New |
| 24 | GTY TECHNOLOGY HOLDINGS INCCUSIP G4182A110 | 0.05 | 0.44% | 4.40 - | $10.35 | - | $10.50 | 0.00 | 1.50 | -$0.00B-1.43% | Held |
| 25 | PARATEK PHARMACEUTICALS INCCUSIP 699374302 | 0.03 | 0.30% | 2.39 - | $13.00 | - | $29.51 | 0.00 | 3.50 | -$0.04B-55.95% | Held |
Showing 1-25 of 33
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Exited Holdings
Stocks no longer disclosed in the current 13F portfolio for 2018 Q1.
| 1 | EXPRESS SCRIPTS HLDG CO COMESRX | 2.31 | 1.00 | $64.83 | $74.64 | +$0.02B+15.12% |
| 2 | CASCADIAN THERAPEUTICS INCCUSIP 14740B606 | 8.72 | 1.25 | $4.22 | $3.70 | -$0.00B-12.35% |
| 3 | Sunrun Inc.RUN | 2.85 | 2.50 | $11.19 | $8.93 | -$0.01B-20.23% |
Showing 1-3 of 3
Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.
Exit return shows estimated dollar return on top and percentage return below.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.